An updated concept of coagulation with clinical implications

Journal of the American Dental Association

Volumn 140, Issue 5, 2009, Pages 567-574

  Romney, Gregory ^a  

^a A T STILL UNIVERSITY   (United States)

Author keywords

Cell based model; Coagulation; Coagulation cascade; Hemostasis

Indexed keywords

EID: 67650138158     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2009.0227     Document Type: Article

References (62)

1. Key NS, Geng JG, Bach RR. Tissue factor; from Morawitz to microparticles. Trans Am Clin CUmatol Assoc 2007;118:165-173.
2. Owen CA Jr. Hemostasis: past, present, and future. Mayo Clinic Proc 1980;55(8):505-508.
3. Morawitz P. Die chemie der blugerinnung. Ergebnisse der Physi- ologie 1905;4:307-423. Cited by: Beck EA. The chemistry of blood coagulation: a summary by Paul Morawitz (1905). Thromb Haemost
4. 1977;37(3):376-379.
5. Boulton F. A hundred years of cascading-started by Paul Morawitz (1879-1936), a pioneer of haemostasis and of transfusion. Transfus Med 2006;16(1):1-10.
6. Roberts HR. Oscar Ratnoff: his contributions to the golden era of coagulation research. Br J Haematol 2003;122(2):180-192.
7. Rapaport SI. Blood coagulation and its alterations in hemorrhagic and thrombotic disorders. West J Med 1993;158(2):153-161.
8. Macfarlane RG. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 1964;202 (4931):498-499.
9. Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964;145(3638):1310-1312.
10. Monroe DM, Hoffman M. What does it take to make the perfect clot? Arterioscler Thromb Vase Biol 2006;26(l):41-48.
11. Hoffman M, Monroe DM. Coagulation 2006: a modern view of hemostasis. Hematol Oncol Clin North Am 2007;21(1):1-11.
12. Ratnoff OD, Margolius A Jr. Hageman trait: an asymptomatic disorder of blood coagulation. Trans Assoc Am Physicians 1955;68:149-154.
13. Ratnoff OD, Colopy JE. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest 1955;34(4):602-613.
14. Troy GC. An overview of hemostasis. Vet Clin North Am Small Anim Pract 1988;18(l):5-20.
15. Lämmle B, Griffin JH. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors. Clin Haematol 1985;14(2):281-342.
16. Furie B, Furie BC. Molecular and cellular biology of blood coagulation. N Engl J Med 1992;326(12):800-806.
17. Hoffman M. Remodeling the blood coagulation cascade. J Thromb Thrombolysis 2003;16(l-2):17-20.
18. Nemerson Y. Tissue factor and hemostasis. Blood 1988;71(l):l-8.
19. Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. Thromb Haemost 2001;85(6):958-965.
20. Osterud B, Rapaport SI. Activation of factor DC by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A 1977;74(12):5260-5264.
21. Hoffman M, Monroe DM 3rd, Roberts HR. Activated factor VII activates factors DC and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis 1998;9(suppl 1):S61-S65.
22. Roberts HR, Monroe DM, Oliver JA, Chang JY, Hoffman M. Newer concepts of blood coagulation. Haemophilia 1998;4(4):331-334.
23. Nemerson Y, Esnouf MP. Activation of a proteolytic system by a membrane lipoprotein: mechanism of action of tissue factor. Proc Natl Acad Sci U S A 1973;70(2):310-314.
24. Nemerson Y. The tissue factor pathway of blood coagulation. Semin Hematol 1992;29(3):170-176.
25. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vase Biol 2004;24(6): 1015-1022.
26. Broze GJ Jr. Why do hemophiliacs bleed? Hosp Pract (Off Ed) 1992;27(3):71-74, 79-82, 85-86.
27. Davidson E, Tomlin S. Observations on thromboplastin generations using platelet suspensions prepared by a simplified method. Thromb Diath Haemorrh 1960;5:74-86.
28. Bell WN, Alton HG. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature 1954;174 (4436):880-881.
29. Majerus PW, Miletich JP. Relationship between platelets and coagulation factors in hemostasiB. Annu Rev Med 1978;29:41-49.
30. Walsh PN. Platelet coagulation-protein interactions. Semin Thromb Hemost 2004;30(4):461-471.
31. Monroe DM, Roberts HR, Hoffman M. Platelet procoagulant complex assembly in a tissue factor-initiated system. Br J Haematol 1994; 88(2):364-371.
32. Hoffman M, Monroe DM, Oliver JA, Roberts HR. Factors DCa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood 1995;86(5):1794-1801.
33. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008;359(9):938-949.
34. Riddel JP Jr, Aouizerat BE, Miaskowski C, Lillicrap DP. Theories of blood coagulation. J Pediatr Oncol Nurs 2007;24(3):123-131.
35. Banner DW, D'Arcy A, Chène C, et al. The crystal structure of the complex of blood coagulation factor Vlla with human soluble tissue factor. Nature 1996;380(6569):41-46.
36. Bach RR. Initiation of coagulation by tissue factor. CRC Crit Rev Biochem 1988;23(4):339-368.
37. Wolberg AS, Campbell RA. Thrombin generation, fibrin clot formation and hemostasis. Transfus Apher Sci 2008;38(l):15-23.
38. Roberts HR, Hoffman M, Monroe DM. A cell-based model of thrombin generation. Semin Thromb Hemost 2006;32(suppl l):32-38.
39. Hoffman M, Monroe DM, Roberts HR. Cellular interactions in hemostasis. Haemostasis 1996;26(suppl 1):12-16.
40. Monkovi6 DD, Tracy PB. Activation of human factor V by factor Xa and thrombin. Biochemistry 1990;29(5):1118-1128.
41. Crawley JT, Zanardelli S, Chion CK, Lane DA. The central role of thrombin in hemostasis. J Thromb Haemost 2007;5(suppl 1):95-101.
42. Monroe DM, Hoffman M, Roberts HR. Transmission of a procoag- ulant signal from tissue factor-bearing cell to platelets. Blood Coagul Fibrinolysis 1996;7(4):459-464.
43. Monković DD, Tracy PB. Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. J Biol Chem 1990;265(28):17132-17140.
44. Oliver JA, Monroe DM, Roberts HR, Hoffman M. Thrombin activates factor XI on activated platelets in absence of factor XII. Arte- rioscler Thromb VaBC Biol 1999;19(1):170-177.
45. Gailani D, Broze GJ Jr. Factor XI activation in a revised model of blood coagulation. Science 1991;263(5022):909-912.
46. Schenone M, Furie BC, Furie B. The blood coagulation cascade. Curr Opin Hematol 2004;ll(4):272-277.
47. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vase Biol 2002;22(9):1381-1389.
48. Veldman A, Hoffman M, Ehrenforth S. New insights into the coagulation system and implications for new therapeutic options with recombinant factor Vila. Curr Med Chem 2003;10(10):797-811.
49. Zimmerman LH. Causes and consequences of critical bleeding and mechanisms of blood coagulation. Pharmacotherapy 2007;27 (9 Pt 2):45S-56S.
50. Ichinose A. Physiopathology and regulation of factor XIII. Thromb Haemost 2001;86(l):57-65.
51. Dahlbäck B. Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic dis-eases. J Intern Med 2005;257(3):209-223.
52. Butenas S, Orfeo T, Brummel-Ziedins KE, Mann KG. Tissue factor in thrombosis and hemorrhage. Surgery 2007;142(4 suppl):S2-S14.
53. Suchman AL, Griner PF. Diagnostic uses of the activated partial thromboplastin time and prothrombin time. Ann Intern Med 1986;104 (6):810-816.
54. Curry ANG, Pierce JMT. Conventional and near-patient tests of coagulation. Contin Educ Anaesth Crit Care Pain 2007;7(2):45-50.
55. Quick AJ, Stanley-Brown M, Bancroft FW. A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 1935;190: 501-511.
56. Tripodi A, Caldwell SH, Hoffman M, Trotter JF, Sanyal AJ. Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease. Aliment Pharmacol Ther 2007;26(2):141-148.
57. Bates SM, Weitz JI. Coagulation assays. Circulation 2005;112(4): e53-e60.
58. Kirkwood TB. Calibration of reference thromboplastins and standardisation of the prothrombin time ratio. Thromb Haemost 1983;49 (3):238-244.
59. Langdell RD, Wagner RH, Brinkhous KM. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assay procedure. J Lab Clin Med 1953;41(4): 637-647.
60. Greenberg MS, Glick M, Ship JA. Burket's Oral Medicine. 11th ed. Hamilton, Ontario, Canada: BC Decker; 2008:1-16.
61. Herman WW, Konzelman JL Jr, Sutley SH. Current perspectives on dental patients receiving coumarin anticoagulant therapy. JADA 1997;128(3):327-335.
62. Jeske AH, Suchko GD. Lack of a scientific basis for routine discontinuation of oral anticoagulation therapy before dental treatment (published correction appears in JADA 2004;135[1]:28). JADA 2003; 134(11):1492-1497.